“…Extracellular succinate is a pleiotropic hormone-like metabolite that acts via its receptor, succinate receptor 1 (SUCNR1) (Fernandez-Veledo et al, 2021; He et al, 2004), that is widely expressed in human tissues (Gilissen et al, 2016) including epithelia of the intestine and kidney (Schneider et al, 2018), white adipose tissue and immunological tissue (Rubic et al, 2008). The close relationship between SUCNR1 and many inflammatory and metabolic diseases such as liver fibrosis (Winther et al, 2021), type 2 diabetes (Villanueva-Carmona et al, 2023), rheumatoid arthritis (Littlewood-Evans et al, 2016), dermatitis (Gnana-Prakasam et al, 2011), cancer metastasis (Wu et al, 2020), obesity (Keiran et al, 2019), and hypertension (Sadagopan et al, 2007), make this receptor an attractive target for therapeutic intervention.…”